Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events -: The Scottish Heart Health Study cohort

被引:14
作者
Tavendale, R [1 ]
Parratt, D
Pringle, SD
A'Brook, R
Tunstall-Pedoe, H
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Cardiovasc Epidemiol Unit, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland
[3] Ninewells Hosp & Med Sch, Dept Cardiol, Dundee, Scotland
关键词
coronary artery disease; Chlamydia pneumoniae infection; epidemiology; immune complexes;
D O I
10.1053/euhj.2001.2778
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To investigate the relationship between serum markers of Chlamydia pneumoniae infection and subsequent coronary events. Methods and Results In a nested case-control study, based on the Scottish Heart Health Study cohort. we estimated IgG, IgA and IgM antibodies to C. pneumoniae, and circulating immune complexes containing C pneumoniae antigen in baseline serum samples from 217 cases experiencing a subsequent coronary event during follow-up (mean 7.5 years) and from their matched controls. In men, the proportion of specimens positive for IgG, IgA and IgM antibodies showed no case-control differences (80% vs 80%, 57% vs 53% and 3%, vs 3%, respectively). The odds ratio for a coronary event was 1.00 (95% confidence interval 0.59-1.69) for the presence of IgG antibodies to C. pneumoniae 1.21 (0.76-1.92) for IgA and 0.75 (0.17-3.35) for IgM. Similar results were seen in women. The proportion of specimens with circulating immune complexes with C pneumoniae antigen also showed no case-control differences (12% vs 12%. both sexes combined) with an odds ratio of 1.00 (0.57-1.76). Conclusion Prior infection with C. pneumoniae, as estimated by these markers, does not appear to be a risk factor for subsequent coronary heart disease. (C) 2001 The European Society of Cardiology.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 34 条
[1]   Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection -: The azithromycin in coronary artery disease:: Elimination of myocardial infection with Chlamydia (ACADEMIC) study [J].
Anderson, JL ;
Muhlestein, JB ;
Carlquist, J ;
Allen, A ;
Trehan, S ;
Nielson, C ;
Hall, S ;
Brady, J ;
Egger, M ;
Horne, B ;
Lim, T .
CIRCULATION, 1999, 99 (12) :1540-1547
[2]  
Carstairs V., 1991, DEPRIVATION HLTH SCO
[3]  
CASALI P, 1977, CLIN EXP IMMUNOL, V29, P342
[4]   Chlamydia pneumoniae IgG titres and coronary heart disease:: prospective study and meta-analysis [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Wong, YK ;
Bernardes-Silva, M ;
Ward, M .
BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :208-212
[5]   Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis [J].
Davidson, M ;
Kuo, CC ;
Middaugh, JP ;
Campbell, LA ;
Wang, SP ;
Newman, WP ;
Finley, JC ;
Grayston, JT .
CIRCULATION, 1998, 98 (07) :628-633
[6]   Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression -: A potential link to accelerated arteriosclerosis [J].
Dechend, R ;
Maass, M ;
Gieffers, J ;
Dietz, R ;
Scheidereit, C ;
Leutz, A ;
Gulba, DC .
CIRCULATION, 1999, 100 (13) :1369-1373
[7]   Rabbit model for Chlamydia pneumoniae infection [J].
Fong, IW ;
Chiu, B ;
Viira, E ;
Fong, MW ;
Jang, D ;
Mahony, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) :48-52
[8]   The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies [J].
Glader, CA ;
Boman, J ;
Saikku, P ;
Stenlund, H ;
Weinehall, L ;
Hallmanns, G ;
Dahlén, GH .
EUROPEAN HEART JOURNAL, 2000, 21 (08) :639-646
[9]  
Gupta S, 1997, CIRCULATION, V96, P404
[10]   Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study [J].
Gurfinkel, E ;
Bozovich, G ;
Daroca, A ;
Beck, E ;
Mautner, B .
LANCET, 1997, 350 (9075) :404-407